Kura Oncology (KURA) Metrics: History & Chart

Kura Oncology, Inc.(KURA)

Biotechnology · San Diego, CA

$10.55-0.07 (-0.68%)

Delayed quote: Oct 6, 2026, 2:50 PM EDT

About Kura Oncology, Inc.

Kura Oncology, Inc., a clinical-stage biopharmaceutical company, develops medicines for the treatment of cancer. The company’s first commercial product, KOMZIFTI (ziftomenib), a potent, selective, reversible and oral small molecule menin inhibitor; Darlifarnib, a Phase 1 first-in-human FIT-001 trial which includes multiple cohorts to evaluate darlifarnib in combination with other targeted therapies in large solid tumor indications; and KO-7246, a next-generation menin inhibitor, for use in diabetes and cardiometabolic disorders and additional next-generation menin inhibitors for use in combination with other therapies in solid tumors. The company is headquartered in San Diego, California.

San Diego, CA

260 employees

kuraoncology.com

Healthcare / Biotechnology

Sector: Healthcare
Industry: Biotechnology
CEO: Troy Wilson

View full financials

Third-Party DCF Estimate (FMP)	$15.69
Price Gap vs Third-Party Estimate	+47.73%

7D Total Return	+0.09%
30D Total Return	-19.85%
YTD Total Return	+2.21%
1Y Total Return	+10.97%
3Y Total Return	+21.11%
5Y Total Return	-43.30%
10Y Total Return	+78.73%
15Y Total Return	N/A
20Y Total Return	N/A

2026	+2.21%
2025	+19.29%
2024	-39.43%
2023	+15.87%
2022	-11.36%
2021	-57.13%
2020

CAGR TTM	+10.92%
CAGR 3Y	+6.59%
CAGR 5Y	-10.73%
CAGR 10Y	+5.98%
CAGR 15Y	N/A
CAGR 20Y	N/A

PE Ratio	N/A
PE Ratio Avg TTM	N/A
PE Ratio Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

All Metrics

KURA Valuation Metrics

KURA Stock Price Metrics

KURA Dividend Metrics

KURA Growth Rate Metrics

KURA Discounted Cash Flow Metrics

KURA Returns By Period

KURA Yearly Returns

KURA Average Annual Returns By Period (CAGR)

KURA Revenue Metrics

KURA PE Ratio Metrics

KURA PS Ratio Metrics

KURA PB Ratio Metrics

KURA Price to Free Cash Flow Ratio Metrics

KURA Debt to Equity Ratio Metrics

KURA PEG Ratio Metrics

KURA FCF Yield

KURA Earnings Yield

KURA EBITDA Yield

KURA OCF Yield

KURA EV/EBIT Ratio Metrics

KURA EV/EBITDA Ratio Metrics

KURA EV/Assets Ratio Metrics

KURA EV/Sales Ratio Metrics

KURA Current Ratio Metrics

KURA Quick Ratio Metrics

KURA ROIC Metrics

KURA Return on Assets Metrics

KURA Return on Equity Metrics

KURA Net Profit Margin Metrics

KURA Gross Profit Margin Metrics

KURA Tax Rate Metrics

PS Ratio	12.22
PS Ratio Avg TTM	10.87
PS Ratio Avg 3Y	10.12
Current VS TTM Avg	+12.38%
Current VS 3Y Avg	+20.70%
Current VS 5Y Avg	+20.70%

PB Ratio	19.48
PB Ratio Avg TTM	5.05
PB Ratio Avg 3Y	2.85
Current VS TTM Avg	+285.61%
Current VS 3Y Avg	+582.41%
Current VS 5Y Avg	+694.41%

PFCF Ratio	8.97
PFCF Ratio Avg TTM	6.84
PFCF Ratio Avg 3Y	6.83
Current VS TTM Avg	+31.05%
Current VS 3Y Avg	+31.37%
Current VS 5Y Avg	+31.37%

Debt/Equity Ratio	0.50
Debt/Equity Ratio Avg TTM	0.20
Debt/Equity Ratio Avg 3Y	0.05
Current VS TTM Avg	+154.66%
Current VS 3Y Avg	+864.89%
Current VS 5Y Avg	+1403.40%

PEG Ratio	N/A
PEG Ratio Avg TTM	N/A
PEG Ratio Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

FCF Yield	11.14%
FCF Yield Avg TTM	16.58%
FCF Yield Avg 3Y	16.62%
Current VS TTM Avg	-32.81%
Current VS 3Y Avg	-32.95%
Current VS 5Y Avg	-32.95%

Earnings Yield	N/A
Earnings Yield Avg TTM	N/A
Earnings Yield Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

EBITDA Yield	N/A
EBITDA Yield Avg TTM	N/A
EBITDA Yield Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

OCF Yield	N/A
OCF Yield Avg TTM	N/A
OCF Yield Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

Ev/Ebit Ratio	N/A
Ev/Ebit Ratio Avg TTM	N/A
Ev/Ebit Ratio Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

Ev/Ebitda Ratio	N/A
Ev/Ebitda Ratio Avg TTM	N/A
Ev/Ebitda Ratio Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

Ev/Assets Ratio	1.53
Ev/Assets Ratio Avg TTM	1.25
Ev/Assets Ratio Avg 3Y	1.76
Current VS TTM Avg	+22.69%
Current VS 3Y Avg	-13.00%
Current VS 5Y Avg	-8.31%

Ev/Sales Ratio	11.63
Ev/Sales Ratio Avg TTM	10.07
Ev/Sales Ratio Avg 3Y	9.06
Current VS TTM Avg	+15.46%
Current VS 3Y Avg	+28.42%
Current VS 5Y Avg	+28.42%

Current Ratio	4.73
Current Ratio Avg TTM	5.64
Current Ratio Avg 3Y	10.62
Current VS TTM Avg	-16.12%
Current VS 3Y Avg	-55.45%
Current VS 5Y Avg	-69.36%

Quick Ratio	4.71
Quick Ratio Avg TTM	5.64
Quick Ratio Avg 3Y	10.62
Current VS TTM Avg	-16.39%
Current VS 3Y Avg	-55.64%
Current VS 5Y Avg	-69.49%

ROIC	(67.13%)
ROIC Avg 3Y	(42.15%)
ROIC Avg 5Y	(35.38%)
Current VS 3Y Avg	-59.27%
Current VS 5Y Avg	-89.75%
Current VS 10Y Avg	-93.08%

ROA	(50.49%)
ROA Avg TTM	(10.99%)
ROA Avg 3Y	(9.84%)
Current VS TTM Avg	-359.54%
Current VS 3Y Avg	-413.37%
Current VS 5Y Avg	-483.98%

ROE	(612.78%)
ROE Avg TTM	(239.96%)
ROE Avg 3Y	(57.00%)
Current VS TTM Avg	-155.36%
Current VS 3Y Avg	-975.12%
Current VS 5Y Avg	-1625.44%

Net Profit Margin	(384.30%)
Net Profit Margin Avg TTM	(397.15%)
Net Profit Margin Avg 3Y	(186.81%)
Current VS TTM Avg	+3.24%
Current VS 3Y Avg	-105.72%
Current VS 5Y Avg	-232.32%

Gross Profit Margin	94.73%
Gross Pft Margin Avg TTM	96.00%
Gross Pft Margin Avg 3Y	52.31%
Current VS TTM Avg	-1.32%
Current VS 3Y Avg	+81.11%
Current VS 5Y Avg	+192.56%

Tax Rate	(0.11%)
Tax Rate Avg 3Y	(0.32%)
Tax Rate Avg 5Y	(0.21%)
Current VS 3Y Avg	+65.63%
Current VS 5Y Avg	+48.44%
Current VS 10Y Avg	-21.00%